Effect of Intravenous Administration of C1-inhibitor on Inflammation and Coagulation after Bronchial Instillation of House Dust Mite Allergen and Lipopolysaccharide in Allergic Asthma Patients

Trial Profile

Effect of Intravenous Administration of C1-inhibitor on Inflammation and Coagulation after Bronchial Instillation of House Dust Mite Allergen and Lipopolysaccharide in Allergic Asthma Patients

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Feb 2017

At a glance

  • Drugs Complement C1 inhibitor protein (Primary)
  • Indications Allergic asthma
  • Focus Pharmacodynamics
  • Acronyms CAST-study
  • Most Recent Events

    • 02 Sep 2016 Planned number of patients changed from 40 to 60.
    • 29 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top